Minimally Invasive Management of Urologic Disease in the Horseshoe Kidney

Posted by Richard E. Link, MD, PhD | Sep 2019

Richard E. Link, MD, PhD, presented “Minimally Invasive Management of Urologic Disease in the Horseshoe Kidney” during the 24th Annual Innovations in Urologic Practice on September 14, 2019 in Santa Fe, New Mexico.

How to cite: Link, Richard E. “Minimally Invasive Management of Urologic Disease in the Horseshoe Kidney” September 14, 2019. Accessed Apr 2024. https://grandroundsinurology.com/minimally-invasive-management-of-urologic-disease-in-the-horseshoe-kidney/

Minimally Invasive Management of Urologic Disease in the Horseshoe Kidney – Summary:

Richard E. Link, MD, PhD, provides an overview of the critical anatomic features of horseshoe kidneys in adults and how these features should factor into treatment decision-making. He describes how the presence of a horseshoe kidney can affect the management of ureteral obstruction and nephrolithiasis, and technical surgical considerations in these cases.

About the 24th Annual Innovations in Urologic Practice

Innovations in Urologic Practice (Innovations) is an annual, multi-day, CME-accredited conference devoted to innovative diagnostic and treatment strategies for and controversies related to some of the most common urologic problems in the current era. The topics covered include oncological management of the bladder, kidney, and prostate. The conference also emphasizes general urology topics in pelvic reconstruction and trauma, men’s health, and infections in the urology patient. Dr. Link presented this lecture during the 24th Innovations in 2019. Please visit this page in order to register for future Innovations meetings.

About The Author

Richard E. Link, MD, PhD

Richard E. Link, MD, PhD, Professor of Urology and the Carlton-Smith Endowed Chair in Urologic Education at the Baylor College of Medicine (BCM) in Houston, Texas, is a Board-certified and fellowship-trained urologist specializing in the treatment of urologic disease affecting the kidneys, ureter, and prostate. He focuses on the use of laparoscopic, robotic-assisted, percutaneous, and endoscopic techniques to treat kidney tumors, renal and ureteral obstruction, and urinary tract stones. He directs the BCM Division of Endourology and Minimally Invasive Surgery and is active nationally in teaching these techniques to other urologists through the American Urological Association Office of Education. He has also directed the BCM fellowship program in Minimally Invasive Urologic Surgery since 2008. He is the recipient of several awards specifically recognizing his commitment to teaching and mentoring, including two Fulbright and Jaworski LLP Faculty Excellence Awards (Teaching and Evaluation and Development of Enduring Materials) and several Resident Teaching Awards. Dr. Link has been an early pioneer in the development of laparoendoscopic single-site donor nephrectomy. He serves as Director of Living Donor Procurement for several major kidney transplant programs in Houston, including CHI/SLEH/BCM, Texas Children’s Hospital, and the Houston Methodist Hospital. Dr. Link completed his PhD in Molecular and Cellular Physiology at Stanford University, CA. His research laboratory studies the genetic basis for renal cell carcinoma disease using a combination of genetically engineered mouse models, stem cell biology, and sophisticated whole genome molecular techniques. His clinical research interests include surgical simulation, decision analysis modeling, and the application of 3D reconstruction and printing techniques to surgical education.

Join the GRU Community

- Why Join? -

Share This

Chat with usLiveChat